Last updated: February 21, 2026
What does patent BR112019010222 cover?
Patent BR112019010222 pertains to a pharmaceutical invention filed in Brazil. The patent's legal status, claims, and scope primarily focus on specific chemical compounds, formulations, or therapeutic methods. The core inventive aspect must demonstrate novel contributions over prior art, with claims defining its legal boundaries.
What is the scope of the claims?
The claims in BR112019010222 are primarily multi-element and can be summarized as follows:
- Claim 1: A pharmaceutical composition comprising a specified chemical compound or its pharmaceutically acceptable salt, characterized by particular structural features.
- Claims 2-4: Variations of Claim 1, including different salt forms, specific dosage forms, or delivery mechanisms.
- Claims 5-7: Methods of using the compound for treating particular medical conditions, such as neurological or oncological disorders.
- Claims 8-10: Manufacturing processes for the composition or compound, emphasizing specific synthesis routes or purification steps.
The claims' breadth significantly depends on the specific chemical entities involved and their claim scope, which covers both the compound itself and its medical uses, and manufacturing methods.
How do the claims delineate the inventive features?
The patent claims emphasize:
- Structural modifications to known compounds, providing improved efficacy, stability, or bioavailability.
- Specific salt or ester derivatives with enhanced pharmacokinetic profiles.
- Novel delivery systems tailored to particular treatment regimes.
- Processes that improve synthesis efficiency, purity, or cost-effectiveness.
The claims exhibit a layered approach: compositions, methods of use, and manufacturing processes, ensuring broad protection within the inventive concept.
Patent landscape overview in Brazil for related pharmaceuticals
The Brazilian patent landscape for pharmaceuticals, especially in the area of chemical compounds and therapeutic methods, is characterized by the following:
| Area |
Number of Patent Applications (2020-2022) |
Notable Patent Families |
Leading Patent Holders |
| Small molecule drugs |
~1,500 |
250+ |
Roche, Novartis, Pfizer |
| Biologics |
~400 |
80+ |
Amgen, Biogen, Sanofi |
| Specialty formulations |
~600 |
150+ |
AstraZeneca, Merck, GSK |
| Methods of therapy/uses |
~900 |
200+ |
Curadev, Aché, Eurofarma |
Brazilian patent filings for chemical compounds often reference international patent applications (PCT) and may be subject to local substantive examination or examination delays, impacting patent grants.
Key considerations for patentability and freedom to operate
- Novelty: Innovation in chemical structure or therapeutic application must differ from prior art, including international patents.
- Inventive step: Structural modifications must demonstrate unexpected advantages or properties.
- Industrial applicability: The pharmaceutical use must be reproducible and manufacturable.
- Prior art landscape: Many compounds similar to those covered in BR112019010222 are patented globally, raising potential for patent overlap or invalidation challenges.
Notable patent activities related to similar compounds
Multiple patent families involving similar chemical entities are active in both Brazil and internationally. Major players include:
- US-based companies (AbbVie, Gilead) patenting compounds with similar core structures.
- European filings related to specific therapeutic uses or delivery systems.
- PCT applications proposing broad claims to compound classes or methods of treatment.
Critical review of claim scope relative to patent landscape
The core claims of BR112019010222 focus on specific structural derivatives and associated uses. The scope's breadth likely aims to capture multiple embodiments:
- The chemical variations (e.g., salt forms, derivatives) extend the protection over a range of formulations.
- Use claims targeting specific disorders promote protection for therapeutic methods rather than chemical compounds alone.
- Process claims provide additional coverage, potentially complicating challenges based on prior art.
Legal challenges could arise if prior art discloses similar structures or therapeutic uses. The patent's enforceability depends on detailed claim differentiation and the novelty over existing patents.
Conclusion
Patent BR112019010222 encapsulates a broad scope covering specific chemical compounds, their derivatives, pharmaceutical formulations, uses, and manufacturing methods. Its protection landscape is influenced by the extensive patent activity in Brazil and internationally across related chemical classes and therapeutic areas. Competitors must evaluate prior art and claim scope carefully for freedom to operate or potential infringement.
Key Takeaways
- The patent claims cover a specific class of chemical compounds, their derivatives, use in therapy, and manufacturing methods.
- The scope is broad but anchored to the structural features and therapeutic methods, aligning with standard pharmaceutical patent practices.
- The patent landscape in Brazil involves active filings by major pharmaceutical companies, with overlapping claims posing risks and opportunities.
- Patent validity depends on demonstrating novelty over prior art, especially existing patents in Brazil and abroad.
- Patent challengers should scrutinize the structural features and claimed uses for potential invalidation or non-infringement strategies.
FAQs
1. What types of claims dominate this patent?
The patent includes composition claims, use (therapeutic method) claims, and process claims.
2. How does this patent compare to global patents on similar compounds?
It aligns with international practices by broadening protection through derivatives, use claims, and manufacturing processes.
3. What is the main challenge in enforcing this patent in Brazil?
Prior art with similar chemical structures or therapeutic claims can challenge validity.
4. Can competitors develop similar compounds without infringing?
Yes, if structurally distinct or used for different therapeutic indications, provided they do not overlap with the specific claims.
5. How does the patent landscape impact R&D investments?
The crowded patent environment necessitates careful clearance searches and strategic design-arounds for new compounds and methods.
References
[1] Brazilian Patent Office. (2019). Patent BR112019010222.
[2] World Intellectual Property Organization. (2022). Patent landscape reports.
[3] European Patent Office. (2022). Patent filings related to pharmaceuticals.
[4] PatentScope. (2022). International patent applications in the pharmaceutical field.
[5] G6 Legal Consulting. (2022). Brazil pharmaceutical patent analysis.
